This forecast statistic shows the revenue of biotechnology R&D in Turkey from 2009 to 2014, with forecasts up until 2020. By 2015, revenues of biotechnology R&D in Turkey are projected to reach approximately 22.65 million U.S. dollars.
Revenue of biotechnology R&D (EFIS (NACE) 7211) in Turkey from 2009 to 2020 (in million U.S. dollars)
Loading statistic...
Other statistics that may interest you Biotechnology industry in Europe
Overview
4
- Premium Statistic Global biotech drug sales estimate 2012-2024
- Basic Statistic Percentage of global pharmaceutical sales by technology 2016-2030
- Premium Statistic Leading European pharmaceutical & biotechnology companies by market cap 2024
- Basic Statistic Leading pharmaceutical & biotech companies in selected EU countries 2022
Research and Development
4
- Premium Statistic European Union: share of GDP expenditure on research and development 2000-2022
- Basic Statistic Public expenditure on biotechnology research & development in Europe 2021
- Basic Statistic Number of biotechnology R&D enterprises in the UK 2008-2022
- Premium Statistic Distribution of biotech companies in Italy 2022, by field of application
Financing and M&As
7
- Basic Statistic Leading European biotechnology companies by venture financing 2023
- Basic Statistic Value of top European biotech IPOs in 2023
- Basic Statistic Select M&As involving U.S. and European biotech companies 2023
- Basic Statistic Value of completed European biopharma company trade sales 2009-2019
- Premium Statistic Largest European biopharma company trade sales 2019
- Premium Statistic Capital inflow of biotechnology companies in Europe from 2008 to 2020
- Basic Statistic Alliances in U.S. and Europe biotech companies by focus 2019
Patents
4
- Premium Statistic Companies with the most patent applications in the biotechnology field 2020
- Premium Statistic Number of biotechnology patents in Europe 2021
- Basic Statistic Number of biotechnology patents in the EU-27 countries 2005-2021
- Basic Statistic Number of biotechnology patents in the United Kingdom (UK) 2005-2021
Countries
5
- Basic Statistic Number of biotechnology R&D enterprises in the UK 2008-2022
- Premium Statistic Revenue value from biotechnology companies in Germany 2008-2022
- Premium Statistic Revenue distribution of the biotech sector in Italy 2021, by field of application
- Premium Statistic Companies performing biotechnology activities Spain in 2020, by relevance
- Basic Statistic Revenues of Swiss biotech companies 2015-2023
Further related statistics
9
- Hourly wages of dishwashers in the U.S. 2022-2023, by percentile distribution
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Global ITO and BPO - Value of industrywide contracts 2012
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Information technology outsourcing market by function 2006-2011
Further Content: You might find this interesting as well
Statistics
- Hourly wages of dishwashers in the U.S. 2022-2023, by percentile distribution
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Global ITO and BPO - Value of industrywide contracts 2012
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Information technology outsourcing market by function 2006-2011
Statista. (February 15, 2017). Revenue of biotechnology R&D (EFIS (NACE) 7211) in Turkey from 2009 to 2020 (in million U.S. dollars) [Graph]. In Statista. Retrieved October 15, 2024, from https://www.statista.com/forecasts/413952/turkey-biotechnology-r-d-revenue-forecast-efis-nace-7211
Statista. "Revenue of biotechnology R&D (EFIS (NACE) 7211) in Turkey from 2009 to 2020 (in million U.S. dollars)." Chart. February 15, 2017. Statista. Accessed October 15, 2024. https://www.statista.com/forecasts/413952/turkey-biotechnology-r-d-revenue-forecast-efis-nace-7211
Statista. (2017). Revenue of biotechnology R&D (EFIS (NACE) 7211) in Turkey from 2009 to 2020 (in million U.S. dollars). Statista. Statista Inc.. Accessed: October 15, 2024. https://www.statista.com/forecasts/413952/turkey-biotechnology-r-d-revenue-forecast-efis-nace-7211
Statista. "Revenue of Biotechnology R&d (Efis (Nace) 7211) in Turkey from 2009 to 2020 (in Million U.S. Dollars)." Statista, Statista Inc., 15 Feb 2017, https://www.statista.com/forecasts/413952/turkey-biotechnology-r-d-revenue-forecast-efis-nace-7211
Statista, Revenue of biotechnology R&D (EFIS (NACE) 7211) in Turkey from 2009 to 2020 (in million U.S. dollars) Statista, https://www.statista.com/forecasts/413952/turkey-biotechnology-r-d-revenue-forecast-efis-nace-7211 (last visited October 15, 2024)
Revenue of biotechnology R&D (EFIS (NACE) 7211) in Turkey from 2009 to 2020 (in million U.S. dollars) [Graph], Statista, February 15, 2017. [Online]. Available: https://www.statista.com/forecasts/413952/turkey-biotechnology-r-d-revenue-forecast-efis-nace-7211